cagrilintide trial Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study Updates in Medicine | 🔬

It is difficult to predict the timing, duration, and potential adverse effects (e.g., portfolio liquidity) of events

Understanding these mechanisms helps researchers design more effective protocols and set realistic expectations for outcomes

30, 37 In more general terms, an appreciation of the role that mast cells would play not only in allergic and acute inflammation, but also in chronic settings, has recently emerged and being appreciated

The peptide therapy isnt a substitute for good skincare and lifestyle habits

But their study suggests that a drug that restores this balance could treat the condition, even in adults